Side-by-side financials for CCCC and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CCCC | ARGX |
|---|---|---|
| Market cap | - | $55.63 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $35.95M | - |
| Net income (latest FY) | -$104.99M | - |
| Net margin | -292.1% | - |
| SEC filings | 516 | 272 |
Full pages: C4 Therapeutics, Inc. and ARGENX SE, or browse the full rankings.